Haldosén L A, Gustafsson J A
Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, Sweden.
Biochem J. 1988 Jun 1;252(2):509-14. doi: 10.1042/bj2520509.
The presence of lactogenic and somatogenic binding sites in intact microsomal membranes and in detergent-solubilized microsomal membrane preparations of female rat liver has been studied by affinity cross-linking-SDS/polyacrylamide-gel electrophoresis. In microsomal membrane preparations an Mr 40,000 lactogenic binder is present which is not disulphide-linked to another protein. Triton X-100 solubilization of membranes results in the appearance of three lactogenic 125I-human growth hormone (125I-hGH) binders with Mr values of 87,000, 40,000 and 35,000, and one somatogenic 125I-hGH binder with Mr 32,000. Treatment of rats with oestrogen increased the amount of lactogenic and somatogenic binding species in liver. The lactogenic binding sites are present as one entity in Triton X-100-solubilized preparations, clearly separated from the somatogenic binder as analysed by gel chromatography. Furthermore, 125I-hGH interacts with an Mr 95,000 somatogenic binder in membrane preparations to which the hormone can be cross-linked only following Triton X-100 solubilization.
通过亲和交联-SDS/聚丙烯酰胺凝胶电泳,研究了完整微粒体膜以及雌性大鼠肝脏去污剂增溶微粒体膜制剂中催乳素结合位点和生长激素结合位点的存在情况。在微粒体膜制剂中存在一种分子量为40,000的催乳素结合蛋白,它不与另一种蛋白质形成二硫键连接。用Triton X-100增溶膜后,出现了三种分子量分别为87,000、40,000和35,000的催乳素125I-人生长激素(125I-hGH)结合蛋白,以及一种分子量为32,000的生长激素125I-hGH结合蛋白。用雌激素处理大鼠可增加肝脏中催乳素和生长激素结合蛋白的量。在Triton X-100增溶制剂中,催乳素结合位点作为一个整体存在,通过凝胶色谱分析,它与生长激素结合蛋白明显分开。此外,125I-hGH在膜制剂中与一种分子量为95,000的生长激素结合蛋白相互作用,只有在Triton X-100增溶后,该激素才能与这种结合蛋白交联。